Ponte Vedra Beach, Florida (PRWEB) July 11, 2013
This week's top news item on HealthEconomics.Com included the results from a Standard & Poor Rating Service report, reflecting agency concerns that Big Pharma’s current American pricing flexibility may diminish over the next few years. They suggest the reasons are due to the rapidly growing costs of Medicare and Social Security with the aging of the U.S. population, and public and private sector healthcare payers looking to control their medical expenses. The story summary can be viewed on HealthEconomics.Com, and was originally sourced from the Healthcare Payer News edition, dated June 28, 2013.
Another popular story from the HealthEconomics.Com newsletter was based on the results from the Organization for Economic Cooperation and Development (OECD) Health Data 2013 report, showing that health spending remained flat for OECD countries in 2011, but pharmaceutical spending experienced deep cuts during the same year. Only two countries, Israel and Japan, experienced an increase in health spending since 2009 compared with the period before, and United States health spending as a portion of the Gross Domestic Product remained stable at 17.7% from 2009 to 2011. The original OECD report was summarized in PharmaTimes Online on July 3, 2013.
A third most-popular story on HealthEconomics.Com was an article describing the explosive growth in the worldwide virtual conference market, estimated to grow at a compound annual growth rate of 56% between 2013 and 2018. The story explored the use of Virtual Trade Shows and Marketplaces for the health care managed markets arena and the use of a newly-launched service by HealthEconomics.Com, called HE-Xpo. HE-Xpo is uniquely positioned to address the educational and informational needs of payers, pharmaceutical industry executives, and healthcare providers, as described in this document.
About HealthEconomics.Com (http://www.healtheconomics.com):
A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.
News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.
Read the full story at http://www.prweb.com/releases/HealthEconomicsCom/TopStories/prweb10918348.htm.
Copyright©2012 Vocus, Inc.
All rights reserved